{"id":"https://openalex.org/W2590446331","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.6122","title":"Was it worth it (WIWI)? Patient satisfaction with clinical trial participation: Results from North Central Cancer Treatment Group (NCCTG) phase III trial N0147.","display_name":"Was it worth it (WIWI)? Patient satisfaction with clinical trial participation: Results from North Central Cancer Treatment Group (NCCTG) phase III trial N0147.","publication_year":2011,"publication_date":"2011-05-20","ids":{"openalex":"https://openalex.org/W2590446331","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.6122","mag":"2590446331"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2011.29.15_suppl.6122","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.6122","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.6122","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5113667219","display_name":"Jeffrey A. Sloan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. A. Sloan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004280495","display_name":"M. R. Mahoney","orcid":"https://orcid.org/0000-0003-0100-425X","observed_orcids":["https://orcid.org/0000-0003-0100-425X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. R. Mahoney","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023299002","display_name":"Daniel J. Sargent","orcid":"https://orcid.org/0000-0002-2684-4741","observed_orcids":["https://orcid.org/0000-0002-2684-4741"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. J. Sargent","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085345701","display_name":"J. M. Hubbard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. M. Hubbard","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082585710","display_name":"H. Liu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"H. Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091400921","display_name":"Ethan Basch","orcid":"https://orcid.org/0000-0003-3813-9318","observed_orcids":["https://orcid.org/0000-0003-3813-9318"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. M. Basch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111979168","display_name":"A. F. Shields","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. F. Shields","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"E. Chan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Chan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080788977","display_name":"Richard M. Goldberg","orcid":"https://orcid.org/0000-0003-0308-8223","observed_orcids":["https://orcid.org/0000-0003-0308-8223","https://orcid.org/0000-0003-3713-6895"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. M. Goldberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"S. Gill","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Gill","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034306031","display_name":"Morton S. Kahlenberg","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. S. Kahlenberg","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5019214686","display_name":"Steven R. Alberts","orcid":"https://orcid.org/0000-0002-5835-4122","observed_orcids":["https://orcid.org/0000-0002-5835-4122"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. R. Alberts","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":21,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"29","issue":"15_suppl","first_page":"6122","last_page":"6122"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10582","display_name":"Ethics in Clinical Research","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10582","display_name":"Ethics in Clinical Research","score":0.9735999703407288,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.010599999688565731,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/patient-satisfaction","display_name":"patient satisfaction","score":0.8320000171661377},{"id":"https://openalex.org/keywords/cancer-clinical-trials","display_name":"cancer clinical trials","score":0.8130000233650208},{"id":"https://openalex.org/keywords/clinical-trial-participation","display_name":"clinical trial participation","score":0.6069999933242798},{"id":"https://openalex.org/keywords/stage-iii-colon-cancer","display_name":"stage III colon cancer","score":0.8679999709129333},{"id":"https://openalex.org/keywords/folfox","display_name":"FOLFOX","score":0.8960000276565552},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9929999709129333},{"id":"https://openalex.org/keywords/quality-of-life","display_name":"quality of life","score":0.6790000200271606},{"id":"https://openalex.org/keywords/elderly-patients","display_name":"elderly patients","score":0.6589999794960022},{"id":"https://openalex.org/keywords/treatment-related-toxicity","display_name":"treatment toxicity","score":0.5009999871253967},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.5770000219345093},{"id":"https://openalex.org/keywords/north-central-cancer-treatment-group","display_name":"North Central Cancer Treatment Group","score":0.7509999871253967},{"id":"https://openalex.org/keywords/trial-design","display_name":"trial design","score":0.3540000021457672},{"id":"https://openalex.org/keywords/trial-completion","display_name":"trial completion","score":0.367000013589859},{"id":"https://openalex.org/keywords/trial-discontinuation","display_name":"trial discontinuation","score":0.42399999499320984}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9184008836746216},{"id":"https://openalex.org/C2778260052","wikidata":"https://www.wikidata.org/wiki/Q117636","display_name":"FOLFOX","level":5,"score":0.6990640163421631},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.6421616077423096},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5799408555030823},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.5633702278137207},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.5458337664604187},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5194354057312012},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48934000730514526},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.42109400033950806},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.372574120759964},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.3516201972961426},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2711450457572937},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.2512630224227905}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2011.29.15_suppl.6122","doi":"https://doi.org/10.1200/jco.2011.29.15_suppl.6122","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2011.29.15_suppl.6122","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.46000000834465027,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2560759455","https://openalex.org/W2465099763","https://openalex.org/W2047962734","https://openalex.org/W2885989590","https://openalex.org/W2920819208","https://openalex.org/W2380114967","https://openalex.org/W2212199444","https://openalex.org/W3144406821","https://openalex.org/W3035301382","https://openalex.org/W2166441124"],"abstract_inverted_index":{"6122":[0],"Background:":[1],"Despite":[2],"the":[3,24,54,69,249,254],"potential":[4],"therapeutic":[5],"advantage,":[6],"only":[7],"approximately":[8],"5%":[9],"of":[10,20,78,148,244],"eligible":[11],"adult":[12],"cancer":[13],"patients":[14,22,111,149,187,207,234,240],"enter":[15],"oncology":[16],"clinical":[17,25],"trials.":[18],"Knowledge":[19],"whether":[21],"thought":[23],"trial":[26,40,117,144,193],"experience":[27],"was":[28,85,97,107,119,139,154,171,181,195,225,263],"beneficial":[29],"may":[30],"provide":[31],"insights":[32],"for":[33,93],"barriers":[34],"to":[35,63,131,157,168,177,183,191,220,227,248,253,258,266,278,291,333],"accrual":[36],"and":[37,135,174,202,238,281],"inform":[38],"future":[39,286],"design.":[41],"A":[42],"recent":[43],"phase":[44],"III":[45,49],"study":[46],"in":[47,285],"stage":[48],"colon":[50],"cancer,":[51],"N0147,":[52,233],"included":[53,284],"5-item":[55],"\u201cWas":[56],"It":[57],"Worth":[58,306],"It\u201d":[59],"(WIWI)":[60],"patient":[61,65,261],"questionnaire":[62],"assess":[64],"satisfaction.":[66],"We":[67],"report":[68,221],"results":[70],"here.":[71],"Methods:":[72],"Patients":[73,161],"received":[74],"12":[75],"bi-weekly":[76],"cycles":[77],"FOLFOX":[79,295,296],"alone":[80],"or":[81],"with":[82,163,236],"cetuximab.":[83],"WIWI":[84,95,105],"completed":[86],"at":[87],"treatment":[88,159,184,267],"discontinuation.":[89],"Comparisons":[90],"between":[91],"groups":[92],"each":[94],"item":[96],"carried":[98],"out":[99],"via":[100],"Fisher\u2019s":[101],"exact":[102],"tests.":[103],"Results:":[104],"data":[106],"provided":[108],"by":[109,141],"1081":[110],"(see":[112],"table).":[113],"The":[114],"majority":[115],"said":[116,151],"participation":[118,170,194],"worth":[120,172,196],"it":[121,125,130,173,200],"(95%),":[122,134],"would":[123,128,198,203],"do":[124,199],"again":[126,201],"(90%),":[127],"recommend":[129,204],"other":[132],"people":[133],"that":[136,222],"their":[137,152,158,179,223,228],"QOL":[138,322],"improved":[140],"going":[142],"on":[143],"(65%).":[145],"Over":[146],"one-third":[147],"(37%)":[150],"satisfaction":[153,180,224,262,270],"not":[155,264],"related":[156,182,226,252,265,332],"outcome.":[160,185,268],"treated":[162,235],"Cmab":[164,237,255],"were":[165,188,214],"less":[166,189],"likely":[167,176,190,216,247],"say":[169,178,192],"more":[175,215],"Elderly":[186],"it,":[197],"it.":[205],"FOLFOX-treated":[206],"aged":[208,212],"70+":[209,303],"versus":[210],"those":[211],"<70":[213,301],"(76%":[217],"vs":[218],"58%)":[219],"outcome":[229],"(p=0.0001).":[230],"Conclusions:":[231],"In":[232],"elderly":[239],"indicated":[241],"lower":[242],"levels":[243],"satisfaction,":[245],"due":[246],"increased":[250],"toxicity":[251],"treatment.":[256],"Contrary":[257],"popular":[259],"belief,":[260],"Patient":[269],"can":[271],"be":[272,283],"assessed,":[273],"is":[274],"a":[275],"sensitive":[276],"measure":[277],"between-arm":[279],"differences,":[280],"should":[282],"randomized":[287],"studies.":[288],"Answered":[289],"yes":[290],".":[292,293,294],"+Cmab":[297],"P":[298,304],"value":[299,305],"Age":[300,302],"it?":[307],"96%":[308,345],"94%":[309,343],"0.01":[310,344],"95%":[311],"92%":[312,346],"0.02":[313],"Do":[314],"again?":[315],"93%":[316],"86%":[317],"0.0001":[318,340],"90%":[319],"84%":[320],"0.004":[321],"improved?":[323],"67%":[324],"64%":[325],"0.13":[326],"66%":[327],"63%":[328],"0.32":[329],"Satisfaction":[330],"level":[331],"outcome?":[334],"60%":[335,338],"65%":[336],"0.05":[337],"78%":[339],"Recommend?":[341],"97%":[342],"0.005":[347]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2025-10-10T00:00:00"}